Howelt® Stands Out Strongly with OTC Approval + Johnson & Johnson Recognition

Howelt® Famotidine, Calcium Carbonate and Magnesium Hydroxide Chewable Tablets is the core product of our company in the digestive field. Initially available as a prescription drug, it could only be dispensed in hospitals. As its advantages of "safety, targeted efficacy, and convenient administration" became increasingly prominent in clinical application, our company took the initiative to apply for the prescription-to-OTC switch in 2014. After a series of processes, the application was successfully approved. Howelt® has transformed from an "exclusive medication" only available in hospitals to a common medication accessible to the public in pharmacies.

Jupoton®: Dual Effects in One Tablet – Innovation of Dual-Layer Composite Formulation

As a technologically breakthrough preparation in the field of compound preparations, Jupoton® Loratadine and Pseudoephedrine Sulfate Sustained-Release Tablets innovatively adopts the immediate-release and sustained-release dual-layer composite formulation technology. By precisely separating the release profiles of the two core ingredients (Loratadine and Pseudoephedrine Sulfate), it meets the clinical demand for "rapid onset of action and long-lasting effect".

Product Centralized Procurement Selection

Product Award

Innovation of Nifedipine: From Short-Acting to Long-Acting

Name Story of JUPOPINE®: From Sustained-Release Tablets (Ⅲ) to Controlled-Release Tablets

JUPOCIN®: 75mg Precise Dosage Enables 24-Hour Long-Acting Efficacy

JUPOKE®: Optimized Dosage Based on the Innovator Product, Better Aligning with the Medication Needs of the Chinese Population